Canon Shareholders Say Firm Can Begin Making, Selling Microarrays | GenomeWeb

NEW YORK, March 30 (GenomeWeb News) - Canon may soon enter the microarray market.


Shareholders of the electronics giant today approved an amendment to the firm's articles of incorporation that will allow Canon to move forward with its plans to produce and commercialize its own line of microarrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.